Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide for Gastrointestinal Angiodysplasia
NCT02622906Phase 2Completed
- Start
- Mar 2012
- Primary completion
- Mar 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pasireotide LAR in gastrointestinal angiodysplasia (GIAD). Started Mar 2012; status: completed.
02
Drugs
pasireotide LAR
03
Conditions
gastrointestinal angiodysplasia (GIAD)
Beyond the preview
Go deeper on NCT02622906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02622906.